pharmaceutical investing Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements